// App-Quantinova.ai

N20 : Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)

Researchers

Presenter

  • S Sider

Principal Investigators

  • L Cococcioni

  • A ElZein

  • S Chadokufa

  • R Buckingham

  • N Shah

  • A Ocholi

  • O Borrelli

  • F Kiparissi

Medical Centers

  • Great Ormond Street Childrens Hospital, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A